Article Search

All Articles
  • All Articles
  • Biologics Zone
  • Blood Management
  • Circuit Surfers
  • COVID-19
  • COVID-19
  • ECMO Zone
  • Education
  • Education Zone
  • HIPEC Zone
  • i-Pump Quick Reference
  • Main Zone
  • Mobile Zone
  • Multimedia Zone
  • Pediatric Zone
  • Perfusion Devices
  • Perfusion Zone
  • Premium Zone
  • Press Release
  • Tiny Perfusion Letter
  • Uncategorized
  • Warnings and Recalls
00B5DC1A-57A4-4243-84E0-E9C6EA358D18

In Memory of Ray Childress

It is with a sad heart we want to inform the perfusion community that Ray Childress passed away this week after a long, brave and hard-fought battle with various health issues.

FDA

CytoSorbents Devices Wins Emergency Approval to Treat COVID-19 Patients

The Food and Drug Administration says it granted Emergency Use Authorization for CytoSorbent’s (NASDAQ:CTSO) CytoSorb device to treat patients with confirmed Covid-19 admitted to the ICU with confirmed or imminent respiratory failure.

Leiters Logo (PRNewsfoto/Leiters)

Leiters Press Release COVID-19

Leiters, a trusted FDA-registered 503B outsourcing provider of high-quality compounded sterile preparations, continues to closely monitor the evolving COVID-19 situation and the potential healthcare drug shortages.

https://circuit.perfusion.com/wp-content/uploads/2014/01/cardiohelp.jpg

Enforcement Policy for Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

The Food and Drug Administration (FDA or Agency) plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.

Sanibel 2020

Sanibel Symposium 2020 Live Webcast with COVID-19 Content

This year’s Sanibel Symposium have special focus on COVID-19 with experts from around the world presenting their experiences and suggestions.